Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PROCEPT BioRobotics (PRCT) Shares Outstanding (Weighted Average) (2020 - 2025)

Historic Shares Outstanding (Weighted Average) for PROCEPT BioRobotics (PRCT) over the last 6 years, with Q3 2025 value amounting to $55.7 million.

  • PROCEPT BioRobotics' Shares Outstanding (Weighted Average) rose 714.46% to $55.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.7 million, marking a year-over-year increase of 714.46%. This contributed to the annual value of $52.1 million for FY2024, which is 1030.58% up from last year.
  • As of Q3 2025, PROCEPT BioRobotics' Shares Outstanding (Weighted Average) stood at $55.7 million, which was up 714.46% from $55.4 million recorded in Q2 2025.
  • PROCEPT BioRobotics' Shares Outstanding (Weighted Average)'s 5-year high stood at $55.7 million during Q3 2025, with a 5-year trough of $4.8 million in Q1 2021.
  • Moreover, its 5-year median value for Shares Outstanding (Weighted Average) was $45.2 million (2023), whereas its average is $40.8 million.
  • Per our database at Business Quant, PROCEPT BioRobotics' Shares Outstanding (Weighted Average) skyrocketed by 80797.1% in 2022 and then soared by 188.61% in 2023.
  • Over the past 5 years, PROCEPT BioRobotics' Shares Outstanding (Weighted Average) (Quarter) stood at $16.5 million in 2021, then soared by 169.42% to $44.4 million in 2022, then increased by 6.43% to $47.3 million in 2023, then grew by 10.31% to $52.1 million in 2024, then grew by 6.91% to $55.7 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $55.7 million for Q3 2025, versus $55.4 million for Q2 2025 and $54.9 million for Q1 2025.